Literature DB >> 15917575

Chromosome-borne class A BOR-1 beta-Lactamase of Bordetella bronchiseptica and Bordetella parapertussis.

Marie-Frédérique Lartigue1, Laurent Poirel, Nicolas Fortineau, Patrice Nordmann.   

Abstract

A narrow-spectrum clavulanic acid-inhibited class A beta-lactamase, BOR-1, was identified in a Bordetella bronchiseptica clinical isolate. It shared 45% amino acid identity with L-2 from Stenotrophomonas maltophilia. An identical beta-lactamase gene was found in B. bronchiseptica and Bordetella parapertussis reference strains that may contribute only in part to their resistance phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15917575      PMCID: PMC1140528          DOI: 10.1128/AAC.49.6.2565-2567.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Biochemical-genetic analysis and distribution of FAR-1, a class A beta-lactamase from Nocardia farcinica.

Authors:  F Laurent; L Poirel; T Naas; E B Chaibi; R Labia; P Boiron; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

2.  Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica.

Authors:  Julian Parkhill; Mohammed Sebaihia; Andrew Preston; Lee D Murphy; Nicholas Thomson; David E Harris; Matthew T G Holden; Carol M Churcher; Stephen D Bentley; Karen L Mungall; Ana M Cerdeño-Tárraga; Louise Temple; Keith James; Barbara Harris; Michael A Quail; Mark Achtman; Rebecca Atkin; Steven Baker; David Basham; Nathalie Bason; Inna Cherevach; Tracey Chillingworth; Matthew Collins; Anne Cronin; Paul Davis; Jonathan Doggett; Theresa Feltwell; Arlette Goble; Nancy Hamlin; Heidi Hauser; Simon Holroyd; Kay Jagels; Sampsa Leather; Sharon Moule; Halina Norberczak; Susan O'Neil; Doug Ormond; Claire Price; Ester Rabbinowitsch; Simon Rutter; Mandy Sanders; David Saunders; Katherine Seeger; Sarah Sharp; Mark Simmonds; Jason Skelton; Robert Squares; Steven Squares; Kim Stevens; Louise Unwin; Sally Whitehead; Bart G Barrell; Duncan J Maskell
Journal:  Nat Genet       Date:  2003-08-10       Impact factor: 38.330

3.  A standard numbering scheme for the class A beta-lactamases.

Authors:  R P Ambler; A F Coulson; J M Frère; J M Ghuysen; B Joris; M Forsman; R C Levesque; G Tiraby; S G Waley
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

4.  Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia.

Authors:  T R Walsh; A P MacGowan; P M Bennett
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

5.  Molecular and biochemical analysis of AST-1, a class A beta-lactamase from Nocardia asteroides sensu stricto.

Authors:  L Poirel; F Laurent; T Naas; R Labia; P Boiron; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

6.  Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates.

Authors:  L Poirel; M Guibert; D Girlich; T Naas; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

Review 7.  Human infections associated with Bordetella bronchiseptica.

Authors:  B F Woolfrey; J A Moody
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

8.  Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa.

Authors:  Delphine Girlich; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

  8 in total
  7 in total

Review 1.  A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.

Authors:  Alain Philippon; Patrick Slama; Paul Dény; Roger Labia
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

Review 2.  Beta-lactamase nomenclature.

Authors:  George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

3.  Antimicrobial Susceptibility of Bordetella bronchiseptica Isolates from Swine and Companion Animals and Detection of Resistance Genes.

Authors:  Sandra Prüller; Ulrike Rensch; Diana Meemken; Heike Kaspar; Peter A Kopp; Günter Klein; Corinna Kehrenberg
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

4.  Molecular and antimicrobial analyses of non-classical Bordetella isolated from a laboratory mouse.

Authors:  Shih Keng Loong; Nur Hidayana Mahfodz; Haryanti Azura Mohamad Wali; Siti Aisyah A Talib; Siti Noraisah Ahmad Nasrah; Pooi Fong Wong; Sazaly Abubakar
Journal:  J Vet Med Sci       Date:  2016-01-17       Impact factor: 1.267

5.  Bordetella hinzii Pneumonia in Patient with SARS-CoV-2 Infection.

Authors:  Hend Ben Lakhal; José Bras Cachinho; Pierre Kalfon; Thierry Naas; Zehaira Benseddik
Journal:  Emerg Infect Dis       Date:  2022-04       Impact factor: 6.883

6.  PAU-1, a Novel Plasmid-Encoded Ambler Class A β-Lactamase Identified in a Clinical Pseudomonas aeruginosa Isolate.

Authors:  Jian Wang; Teng Xu; Jun Ying; Wangxiao Zhou; Qianqian Chen; Changrui Qian; Xinyi Zhu; Kai Shen; Peizhen Li; Kewei Li; Qiyu Bao; Junwan Lu
Journal:  Infect Drug Resist       Date:  2019-12-05       Impact factor: 4.003

7.  A Case of Bordetella bronchiseptica Bacteremia in a Patient With COVID-19: Brief Report.

Authors:  Styliani Papantoniou; Antonios Tsakiris; Theodoros Ladopoulos; Georgios Kranidiotis; Charalampos Tamvakos
Journal:  Cureus       Date:  2021-06-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.